Folotyn

Product NDC
48818-001
Requested package NDC
48818-001-01
11-digit product format
488180001
Labeler code
48818
Product ID
48818-001_dc6e58a9-4f26-460b-b387-41e524d3f9a6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
pralatrexate
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Acrotech Biopharma LLC
Application
NDA022468
Marketing category
NDA
Marketing start
2009-09-24
Marketing end
0000-00-00
Substance
PRALATREXATE
Active strength
20 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage48818-00148818-001-01DDiscontinued by firm2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022468-001FOLOTYNPRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD2009-09-24
N022468-002FOLOTYNPRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD, RS2009-09-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N022468-001AP
N022468-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD2009-09-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD, RS2009-09-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD2009-09-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD, RS2009-09-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD2009-09-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD, RS2009-09-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD2009-09-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAPRLD, RS2009-09-24fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-2403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-2403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-242680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-242680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-245bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-245bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24d06236e962d9…
2024-10-29 15:01 UTC2024-10N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-2479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-2479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-241e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-241e350fbaab3a…
2024-05-31 18:47 UTC2024-05N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-248072bd15b7f6…
2024-05-31 18:47 UTC2024-05N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-248072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-245c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-245c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-245d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-245d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-244b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-244b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-2474a2ff9319b5…
2019-12-13 00:20 UTC2019-12N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-2474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N022468-001FOLOTYN20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSRLD2009-09-24782e0a99824c…
2021-12-28 21:50 UTC2021-12N022468-002FOLOTYN40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSRLD, RS2009-09-24782e0a99824c…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N022468-001AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022468-002AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-001AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-002AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N022468-001AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022468-002AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-001AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-002AP1fd3edfee7708…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N022468-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N022468-002AP1a50c72e98297…

Observed Orange Book patent history#

Patent history page 1 of 5 · 192 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-00176224702025-05-31U-101531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-00182990782025-05-31U-10042012-12-1931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-00276224702025-05-31U-101531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022468-00282990782025-05-31U-100431067a03dcf5…
2025-08-23 18:47 UTC2025-08N022468-00176224702025-05-31U-10156a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022468-00182990782025-05-31U-10042012-12-196a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022468-00276224702025-05-31U-10156a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022468-00282990782025-05-31U-10046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-00176224702025-05-31U-1015fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-00182990782025-05-31U-10042012-12-19fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-00276224702025-05-31U-1015fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022468-00282990782025-05-31U-1004fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-00176224702025-05-31U-1015b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-00182990782025-05-31U-10042012-12-19b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-00276224702025-05-31U-1015b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022468-00282990782025-05-31U-1004b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-00176224702025-05-31U-101503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-00182990782025-05-31U-10042012-12-1903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-00276224702025-05-31U-101503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022468-00282990782025-05-31U-100403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-00176224702025-05-31U-10152680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-00182990782025-05-31U-10042012-12-192680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-00276224702025-05-31U-10152680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022468-00282990782025-05-31U-10042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-00176224702025-05-31U-10155bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-00182990782025-05-31U-10042012-12-195bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-00276224702025-05-31U-10155bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022468-00282990782025-05-31U-10045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-00176224702025-05-31U-1015d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-00182990782025-05-31U-10042012-12-19d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-00276224702025-05-31U-1015d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022468-00282990782025-05-31U-1004d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N022468-00176224702025-05-31U-1015d06236e962d9…
2024-10-29 15:01 UTC2024-10N022468-00182990782025-05-31U-10042012-12-19d06236e962d9…
2024-10-29 15:01 UTC2024-10N022468-00276224702025-05-31U-1015d06236e962d9…
2024-10-29 15:01 UTC2024-10N022468-00282990782025-05-31U-1004d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-00176224702025-05-31U-101579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-00182990782025-05-31U-10042012-12-1979d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-00276224702025-05-31U-101579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022468-00282990782025-05-31U-100479d66fd596c7…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
48818-001-012023-04-18These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-022023-04-18These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-012023-01-30These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-022023-01-30These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-012021-10-08These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-022021-10-08These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-012021-01-29These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
48818-001-022021-01-29These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
48818-001-01ML - Milliliter48818-001b1d0dd02-ec6b-47f7-acdb-42e56d067a7b12012-07-24
48818-001-02ML - Milliliter48818-001c8636418-6888-4641-b710-4b50c3fa231f12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
pralatrexateACTIVE INGREDIENTA8Q8I19Q20FOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17
pralatrexateACTIVE MOIETYA8Q8I19Q20FOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17
hydrochloric acidINACTIVE INGREDIENTQTT17582CBFOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17
sodium chlorideINACTIVE INGREDIENT451W47IQ8XFOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17
sodium hydroxideINACTIVE INGREDIENT55X04QC32IFOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17
waterINACTIVE INGREDIENT059QF0KO0RFOLOTYN (PRALATREXATE) INJECTION [ALLOS THERAPEUTICS]17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FolotynPRALATREXATEAcrotech Biopharma Inc9f3d9c4d-9386-4451-b712-0fbdc5478d8f2024-09-26Warnings, Adverse reactionsExact identifier
application applno (NDA): 022468
application number: NDA022468
PralatrexatePRALATREXATEFresenius Kabi USA, LLCa5daa583-4965-4564-ad87-41ffe6c08a112022-11-15Warnings, Adverse reactionsExact identifier
application applno (NDA): 022468
application number: NDA022468

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
48818-001-01488180001011 VIAL, SINGLE-USE in 1 CARTON (48818-001-01) > 1 mL in 1 VIAL, SINGLE-USE2009-09-242023-06-30NoNoCurrent